Comparing CPAP joint antioxidant carbocysteine therapy and simple CPAP therapy on the effects of blood pressure in patients with OSAHS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-15006614

Enrollment

Unknown

Registered

2015-06-17

Start date

2015-06-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive sleep-apnea hypopnea syndrome

Interventions

1:CPAP

2:CPAP joint carbocysteine

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Untreated patients with moderately severe OSAHS confirmed by our sleep monitoring room; 2) in accordance with the hypertension diagnosis standard.

Exclusion criteria

Exclusion criteria: 1) There are acute infection in 4 weeks, such as respiratory tract, the digestive tract infections; 2) Clear secondary hypertension, such as Heart dysfunction, rena dysfunction and drenal pheochromocytoma; 3) Previous history of gastrointestinal diseases; 4) Refused to participate in this study.

Design outcomes

Primary

Measure	Time frame
blood pressure;	—

Secondary

Measure	Time frame
CRP;MDA;SOD;ET;NO;	—

Countries

China

Contacts

Public ContactZhang Nuofu

nfzhanggird@163.com+86 13600460056

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026